Purpose. The purpose of this study was to develop an animal model of Serrat
ia keratitis that is suitable to demonstrate the pathology of specific stra
ins.
Methods. Serratia marcescens ocular strains 93-1399-1 and 94-EI-185-2, and
an environmental strain (ATCC 14041) were characterized in vitro in terms o
f their motility, metabolic profiles, ribotypes, and protease production. T
he strains were then analyzed in the rabbit intrastromal injection model. S
lit lamp examination (SLE) and enumeration of bacteria in the cornea was co
nducted every 6 hours for 30 hours postinfection. In vivo motilities were a
nalyzed by quantification of bacteria in the peripheral and central areas o
f infected rabbit corneas.
Results. All strains were similar in their metabolic activity and productio
n of extracellular proteases. The ocular isolates were distinct from the en
vironmental strain in their ribotyping patterns and in their motility. Each
strain grew logarithmically in the cornea up to 6 hours post-infection. SL
E scores increased from 0 to 30 hours post-infection for strains ATCC 14041
and 93-1399-1, while the SLE score of strain 94-EI-185-2 reached its maxim
um at 18 hours post-infection. Strain-specific differences in pathology wer
e noted from 18 to 30 hours post-infection. Strain 94-EI-185-2 produced iri
tis but only mild corneal changes. Strain 93-1399-1 produced a severe corne
al infiltrate encompassing the entire corneal surface as well as severe con
junctival inflammation and iritis. Strain ATCC 14041 produced a localized,
severe, exudative corneal abscess that contained infecting bacteria.
Conclusions. A rabbit model of Serratia keratitis was developed in which ba
cterial growth kinetics and strain-specific ocular pathologic changes were
reproducible.